Aytu Biopharma Inc
NASDAQ:AYTU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aytu Biopharma Inc
NASDAQ:AYTU
|
US |
|
B
|
Black Sesame International Holding Ltd
HKEX:2533
|
CN |
|
DCB Bank Ltd
NSE:DCBBANK
|
IN |
|
T
|
TIPCO Asphalt PCL
SET:TASCO
|
TH |
|
K
|
Kekrops SA
ATHEX:KEKR
|
GR |
|
Inter & Co Inc
NASDAQ:INTR
|
BR |
|
Pretium Resources Inc
TSX:PVG
|
CA |
|
Select Medical Holdings Corp
NYSE:SEM
|
US |
|
Eat & Beyond Global Holdings Inc
OTC:DGTEF
|
CA |
|
L
|
Leef Brands Inc
CNSX:LEEF
|
CA |
Wall Street
Price Targets
AYTU Price Targets Summary
Aytu Biopharma Inc
According to Wall Street analysts, the average 1-year price target for
AYTU
is 9.86 USD
with a low forecast of 7.07 USD and a high forecast of 14.7 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AYTU's stock price target?
Price Target
9.86
USD
According to Wall Street analysts, the average 1-year price target for
AYTU
is 9.86 USD
with a low forecast of 7.07 USD and a high forecast of 14.7 USD.
What is Aytu Biopharma Inc's Revenue forecast?
Projected CAGR
13%
For the last 9 years the
compound annual growth rate for
Aytu Biopharma Inc's revenue is
43%.
The projected
CAGR
for the next 3 years is
13%.
What is Aytu Biopharma Inc's Operating Income forecast?
Projected CAGR
17%
The
compound annual growth rate
of Aytu Biopharma Inc's operating income for the next 3 years is
17%.
